MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by COHEN, J. B.
Right arrow Articles by CHANGEUX, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by COHEN, J. B.
Right arrow Articles by CHANGEUX, J.-P.

Molecular Pharmacology, Vol 10, 904-932, Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics

Effects of Local Anesthetics and Calcium on the Interaction of Cholinergic Ligands with the Nicotinic Receptor Protein from Torpedo marmorata

JONATHAN B. COHEN 1, MICHEL WEBER 1, and JEAN-PIERRE CHANGEUX 1

1 Unité de Neurobiologie—Département de Biologie Moléculaire, Institut Pasteur, 75015 Paris, France

Studies are presented of the interaction in a physiological ionic environment of aromatic amine local anesthetics (prilocaine, lidocaine, and dimethisoquin) and Ca++ with receptor-rich membrane fragments isolated from Torpedo electric organ. The environmentaly sensitive fluorophore 1-(5-dimethylaminonaphthalene-1-sulfonamido)ethane 2-trimethylammonium iodide (DNS-chol)interacts with two classes of sites in the membrane fragments: the cholinergic receptor site and secondary sites characterized by probe emission properties (lgrmax) sensitive to the pharmacological nature (agonist or antagonist) of the cholinergic ligand bound to the receptor site. Fluorescence studies show that the local anesthetics cause an increase of affinity of the membrane-bound receptor for DNS-chol and for cholinergic ligands, both agonists and antagonists. The increase of affinity is not associated with a change of DNS-chol emission properties. At the same concentrations at which the anesthetics control receptor affinity, they also affect the fluorescence of DNS-chol bound to the secondary sites: the presence of local anesthetic causes a loss of the DNS-chol spectral properties characteristic of the binding of agonists to the receptor site. Local anesthetics also control the binding of [3H]acetylcholine to the membrane-bound receptor. In the absence of prilocaine the acetylcholine binding curve is slightly sigmoid (Hill coefficient, nH = 1.4, half-saturation at 10 nM free acetylcholine). In the presence of 3 mM prilocaine there is a decrease of cooperativity and an increase of affinity (nH = 1.0, half-saturation at 6 mM free acetylcholine). The concentrations at which the local anesthetics act on the membrane fragments are those at which they block the permeability response of Electrophorus electroplax upon addition to the bath of the agonist carbamylcholine. Fluorescence and radioactive ligand assays demonstrate that Ca++ also causes an increase of receptor affinity for cholinergic ligands, but in a manner significantly different from that observed with local anesthetics. Solubilization of membrane fragments by detergent leads to changes in the binding properties of the receptor protein. On the membrane fragments the binding data for each agonist can be analyzed in terms of a homogeneous population of sites, while after solubilization heterogeneity of the binding constants appears. Prilocaine or Ca+ no longer affects the binding of acetylcholine to the solubilized receptor protein. The observed effects of local anesthetics and Ca++ on the affinity of the cholinergic receptor are related to the phenomenon of receptor desensitization.

Note:
ACKNOWLEDGMENT We thank Professor P. Boquet for a gift of purified Naja agr-toxin; Drs. A. Menez, J. L. Morgat, and P. Fromageot, for its tritiation; Dr. C. Cazaux and his colleagues at the Institut de Biologie Marine, Arcachon, for supplying Torpedo; and Dr. P. Ascher, for a gift of SKF 525-A. Finally, we thank Drs. H. Buc and R. Sealock for their helpful discussions.

Submitted on May 23, 1974




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
S. E. Ryan and J. E. Baenziger
A Structure-Based Approach to Nicotinic Receptor Pharmacology
Mol. Pharmacol., February 1, 1999; 55(2): 348 - 355.
[Abstract] [Full Text]


Home page
ScienceHome page
J. Changeux, A Devillers-Thiery, and P Chemouilli
Acetylcholine receptor: an allosteric protein
Science, September 21, 1984; 225(4668): 1335 - 1345.
[Abstract] [PDF]


Home page
ScienceHome page
M. Raftery, M. Hunkapiller, C. Strader, and L. Hood
Acetylcholine receptor: complex of homologous subunits
Science, June 27, 1980; 208(4451): 1454 - 1456.
[Abstract] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
J.-P. Changeux, L. Benedetti, J.-P. Bourgeois, A. Brisson, J. Cartaud, P. Devaux, H. Grunhagen, M. Moreau, J.-L. Popot, A. Sobel, et al.
Some Structural Properties of the Cholinergic Receptor Protein in Its Membrane Environment Relevant to Its Function as a Pharmacological Receptor
Cold Spring Harb Symp Quant Biol, January 1, 1976; 40(0): 211 - 230.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics